help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2008-0017
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Centenera, M. M.
Right arrow Articles by Butler, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Centenera, M. M.
Right arrow Articles by Butler, L. M.
Molecular Endocrinology 22 (11): 2373-2382
Copyright © 2008 by The Endocrine Society


Minireview

Minireview: The Contribution of Different Androgen Receptor Domains to Receptor Dimerization and Signaling

Margaret M. Centenera, Jonathan M. Harris, Wayne D. Tilley and Lisa M. Butler

Dame Roma Mitchell Cancer Research Laboratories (M.M.C., W.D.T., L.M.B.), Discipline of Medicine, The University of Adelaide and Hanson Institute, Adelaide, Discipline of Physiology (M.M.C.), School of Molecular and Biomedical Science, The University of Adelaide, Adelaide, South Australia 5000, Australia; and Institute of Health and Biomedical Innovation (J.M.H.), Brisbane, Queensland 4059, Australia

Address all correspondence and requests for reprints to: Wayne D. Tilley, Ph.D., Dame Roma Mitchell Cancer Research Laboratories, The University of Adelaide and Hanson Institute, PO Box 14, Rundle Mall, Adelaide, South Australia 5000, Australia. E-mail: wayne.tilley{at}imvs.sa.gov.au.

The androgen receptor (AR) is a ligand-activated transcription factor of the nuclear receptor superfamily that plays a critical role in male physiology and pathology. Activated by binding of the native androgens testosterone and 5{alpha}-dihydrotestosterone, the AR regulates transcription of genes involved in the development and maintenance of male phenotype and male reproductive function as well as other tissues such as bone and muscle. Deregulation of AR signaling can cause a diverse range of clinical conditions, including the X-linked androgen insensitivity syndrome, a form of motor neuron disease known as Kennedy’s disease, and male infertility. In addition, there is now compelling evidence that the AR is involved in all stages of prostate tumorigenesis including initiation, progression, and treatment resistance. To better understand the role of AR signaling in the pathogenesis of these conditions, it is important to have a comprehensive understanding of the key determinants of AR structure and function. Binding of androgens to the AR induces receptor dimerization, facilitating DNA binding and the recruitment of cofactors and transcriptional machinery to regulate expression of target genes. Various models of dimerization have been described for the AR, the most well characterized interaction being DNA-binding domain- mediated dimerization, which is essential for the AR to bind DNA and regulate transcription. Additional AR interactions with potential to contribute to receptor dimerization include the intermolecular interaction between the AR amino terminal domain and ligand-binding domain known as the N-terminal/C-terminal interaction, and ligand-binding domain dimerization. In this review, we discuss each form of dimerization utilized by the AR to achieve transcriptional competence and highlight that dimerization through multiple domains is necessary for optimal AR signaling.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   SRC-1  |  GRIP1  |  AIB1
Ligands:   Dihydrotestosterone



This article has been cited by other articles:


Home page
EndocrinologyHome page
P. Lim, M. Robson, J. Spaliviero, K. J. McTavish, M. Jimenez, J. D. Zajac, D. J. Handelsman, and C. M. Allan
Sertoli Cell Androgen Receptor DNA Binding Domain Is Essential for the Completion of Spermatogenesis
Endocrinology, October 1, 2009; 150(10): 4755 - 4765.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
J. Yang and M. J Young
The mineralocorticoid receptor and its coregulators
J. Mol. Endocrinol., August 1, 2009; 43(2): 53 - 64.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
K. E. Knudsen and H. I. Scher
Starving the Addiction: New Opportunities for Durable Suppression of AR Signaling in Prostate Cancer
Clin. Cancer Res., August 1, 2009; 15(15): 4792 - 4798.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society